Early Rectal Cancer: Endoscopic Submucosal Dissection or Transanal Endoscopic Microsurgery? (MUCEM)
Sponsor: Assistance Publique Hopitaux De Marseille
Terminated
difficulties to recruit all the patients
Other terminated trials from Assistance Publique Hopitaux De Marseille
- Bariatric Surgery · Phase NA · May 2024
- Psoriasis · Phase PHASE4 · Feb 2024
- Persistent ARDS · Phase PHASE3 · Nov 2023
- Paraganglioma · Phase NA · Oct 2023
- Epilepsy · Phase NA · Jun 2023
See all terminations from Assistance Publique Hopitaux De Marseille
Other Anal Cancer trials with similar outcome
This NA trial investigates Anal Cancer and is currently terminated or withdrawn. Assistance Publique Hopitaux De Marseille leads this study, which shows 10 recorded versions since 2016 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
10 versions recorded-
Dec 2025 — Present [monthly]
Terminated NA
-
May 2025 — Dec 2025 [monthly]
Terminated NA
-
Nov 2024 — May 2025 [monthly]
Terminated NA
-
Sep 2024 — Nov 2024 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
▶ Show 5 earlier versions
-
Oct 2023 — Jul 2024 [monthly]
Terminated NA
-
Jul 2023 — Oct 2023 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Jan 2021 — Jul 2023 [monthly]
Unknown Status NA
-
Dec 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
-
Jan 2017 — Dec 2020 [monthly]
Not Yet Recruiting NA
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique Hopitaux De Marseille
For direct contact, visit the study record on ClinicalTrials.gov .